Stefan Sperl
Geschäftsführer bei KIORA PHARMACEUTICALS, INC.
Aktive Positionen von Stefan Sperl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Geschäftsführer | - | - |
Karriereverlauf von Stefan Sperl
Ehemalige bekannte Positionen von Stefan Sperl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Geschäftsführer | 01.07.2013 | - |
| Gründer | 01.07.2013 | - |
Ausbildung von Stefan Sperl
| Max Planck Institute of Biochemistry | Doctorate Degree |
Statistik
International
| Österreich | 3 |
| Vereinigte Staaten | 2 |
| Deutschland | 2 |
Operativ
| Chief Operating Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Börse
- Insiders
- Stefan Sperl
- Erfahrung
